Replies to post #51 on TC BioPharm Holdings Plc (TCBP)

[Cameo Brien]

The Company's IP also covers proprietary know how in the areas of gamma delta t-cell expansion, a core component to the Company's product. TCBP continues to expand it's patent portfolio and IP position, and anticipates filing further patent applications around its proprietary CAR-T platform.